HC Wainwright Reiterates Buy on Connect Biopharma, $7 Target
HC Wainwright & Co. reiterated a Buy rating on Connect Biopharma Hldgs with a price target of $7.00, implying a 614.5% upside from the Oct. 1 close of $0.98.
HC Wainwright & Co. reiterated a Buy rating on Connect Biopharma Hldgs with a price target of $7.00, implying a 614.5% upside from the Oct. 1 close of $0.98.